Dreyer's Grand Ice Cream, Inc. – FDA Warning Letter, Feb 20, 2026

The FDA issued a warning letter to Dreyer’s Grand Ice Cream, Inc. following an inspection of its Bakersfield, California facility conducted between January 27 and February 20, 2026. The inspection identified serious violations of the Hazard Analysis and Risk-Based Preventive Controls for Human Food regulations. Specifically, the FDA found that the company failed to identify Listeria monocytogenes as a significant hazard requiring preventive controls, despite continuous positive test results for the pathogen in the facility environment from 2021 through early 2026. This oversight led the FDA to classify the company’s ready-to-eat ice cream products as adulterated, as they were produced under unsanitary conditions. Additional concerns included poor employee hygiene and inadequate sanitation practices. Investigators observed staff members handling trash, dirty equipment, and non-food-contact surfaces before touching ice cream products and packaging without washing their hands or changing gloves. Furthermore, the facility failed to properly maintain and utilize floor sanitizers and foot baths designed to prevent the spread of contaminants. Although Dreyer’s responded with initial corrective measures, the FDA deemed these efforts insufficient because they did not address long-term environmental remediation or provide a revised hazard analysis. The company is required to submit a written response within 15 working days detailing specific, comprehensive actions taken to rectify these violations and prevent their recurrence. Failure to provide adequate solutions could lead to legal consequences, including product seizure or injunction.